News
Mallinckrodt’s liver disease drug terlipressin edges FDA adv...
An FDA advisory committee has narrowly voted in favour of approval of Mallinckrodt’s terlipressin for hepatorenal syndrome type 1 (HRS-1), after the agency questioned the findi
